PHLEBO-ONLINE / POL N°2 2024

PERRINE ECHEGUT OPENS THE FILE
PELVIC CONGESTION SYNDROME

editorial: Welcome to the world of Phlebology 4.0!

pr aLBERT cLAUDE benhamou

POL AND SAMMI ZERROUK INVITE YOU ON A JOURNEY...

IN FRENCH-SPEAKING AFRICA AT THE HEART OF THE
ALGERIAN SAHARA

Free access to the 4 FLIPBOOKS OF 2023
pav N°1 & 2 then pol N°3 & 4

PAV N°1 2023

PAV N°2 2023

PAV-POL N°3 2023

POL N°4 2023

DISCOVER POL'S INDUSTRIAL PARTNERS

SIGVARIS AND
innovations in medical compression

pub sigvaris

KREUSSLER AND STD
what's new in sclerotherapy?

khreuse

The alliance between Kreussler Pharma and STD Pharma. The world of sclerotherapy on the move: Stephan Travers, Bruce Gardiner and Serge Mako

Sclerotherapy in questions: Matthieu Josnin Varicose veins: myth or reality?

Sclerotherapy in questions: Nicolas Néaume Expected and undesirable effects.

SANOFI
EXPERIENCE has a future... with LOVENOX

From deep vein thrombosis to post-thrombotic disease. Presentation by Frédéric Vin at the French National Academy of Surgery (January 2023).

Interviews with leaders in Phlebology

MAKE A NOTE OF IT IN YOUR DIARIES:

14 & 15 NOVEMBER 2024

THE 82nd SFP CONGRESS IN PARIS

congrès SFP 2024

Authors of SFP journals

The Directors of SFP and POL

The French Society of Phlebology (SFP)

en_GB